Clinical manifestations of halophilic non-cholera Vibrio infections.
D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003967:Diarrhea / Q000209:etiology; D005243:Feces / Q000382:microbiology; D005517:Foodborne Diseases / Q000209:etiology; D005734:Gangrene / Q000209:etiology; D005839:Gentamicins / Q000627:therapeutic use; D006396:Hematemesis / Q000209:etiology; D006801:Humans; D008297:Male; D008551:Melena / Q000209:etiology; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D012623:Seawater; D012871:Skin Diseases / Q000209:etiology; D014733:Vibrio / Q000302:isolation & purification; D014735:Vibrio Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D014871:Water Microbiology
D005839:Gentamicins; D002981:Clindamycin; D000667:Ampicillin; D002512:Cephalothin